Report Hong Kong SAR, China - Medicaments Containing Hormones But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights for 499$
Report Update Nov 1, 2024

Hong Kong SAR, China - Medicaments Containing Hormones But not Antibiotics - Market Analysis, Forecast, Size, Trends and Insights

Single report
Sent by email within 24h (Mon-Fri)
Subscription
Online access and download
from $350/month

Get instant access to more than 2 million reports, dashboards, and datasets on the IndexBox Platform.

View Pricing

Hong Kong SAR, China: Medicaments Containing Hormones Market 2024

Medicaments Containing Hormones Market Size in Hong Kong SAR, China

The Hong Kong medicaments containing hormones market expanded slightly to $X in 2022, increasing by X% against the previous year. Overall, the total consumption indicated temperate growth from 2012 to 2022: its value increased at an average annual rate of X% over the last decade. The trend pattern, however, indicated some noticeable fluctuations being recorded throughout the analyzed period. Based on 2022 figures, consumption decreased by X% against 2020 indices. As a result, consumption reached the peak level of $X. From 2018 to 2022, the growth of the market remained at a somewhat lower figure.

Medicaments Containing Hormones Production in Hong Kong SAR, China

In value terms, medicaments containing hormones production stood at $X in 2022 estimated in export price. Overall, production, however, enjoyed a temperate expansion. The most prominent rate of growth was recorded in 2017 when the production volume increased by X% against the previous year. Over the period under review, production hit record highs at $X in 2020; however, from 2021 to 2022, production remained at a lower figure.

Medicaments Containing Hormones Exports

Exports from Hong Kong SAR, China

In 2022, exports of medicaments containing hormones but not antibiotics from Hong Kong SAR reduced markedly to X tons, waning by X% compared with the previous year. Overall, exports showed a deep reduction. The growth pace was the most rapid in 2016 when exports increased by X% against the previous year. The exports peaked at X tons in 2012; however, from 2013 to 2022, the exports remained at a lower figure.

In value terms, medicaments containing hormones exports shrank markedly to $X in 2022. Over the period under review, exports continue to indicate a abrupt decline. The pace of growth appeared the most rapid in 2020 when exports increased by X%. The exports peaked at $X in 2012; however, from 2013 to 2022, the exports stood at a somewhat lower figure.

Exports by Country

The Philippines (X kg) was the main destination for medicaments containing hormones exports from Hong Kong SAR, with a approx. X% share of total exports.

From 2012 to 2022, the average annual rate of growth in terms of volume to the Philippines amounted to X%.

In value terms, the Philippines ($X) also remains the key foreign market for medicaments containing hormones but not antibiotics exports from Hong Kong SAR.

From 2012 to 2022, the average annual growth rate of value to the Philippines stood at X%.

Export Prices by Country

The average medicaments containing hormones export price stood at $X per ton in 2022, reducing by X% against the previous year. Over the period under review, the export price, however, posted a remarkable increase. The pace of growth appeared the most rapid in 2020 when the average export price increased by X%. Over the period under review, the average export prices reached the maximum at $X per ton in 2021, and then contracted dramatically in the following year.

As there is only one major export destination, the average price level is determined by prices for the Philippines.

From 2012 to 2022, the rate of growth in terms of prices for Malaysia amounted to X% per year.

Medicaments Containing Hormones Imports

Imports into Hong Kong SAR, China

In 2022, the amount of medicaments containing hormones but not antibiotics imported into Hong Kong SAR skyrocketed to X tons, with an increase of X% against 2021. Over the period under review, imports, however, saw a noticeable contraction. Imports peaked at X tons in 2014; however, from 2015 to 2022, imports stood at a somewhat lower figure.

In value terms, medicaments containing hormones imports surged to $X in 2022. Overall, imports enjoyed resilient growth. Over the period under review, imports attained the maximum at $X in 2020; however, from 2021 to 2022, imports remained at a lower figure.

Imports by Country

In 2022, Australia (X kg) constituted the largest medicaments containing hormones supplier to Hong Kong SAR, accounting for a X% share of total imports. Moreover, medicaments containing hormones imports from Australia exceeded the figures recorded by the second-largest supplier, Italy (X kg), threefold. The United States (X kg) ranked third in terms of total imports with a X% share.

From 2012 to 2022, the average annual growth rate of volume from Australia amounted to X%. The remaining supplying countries recorded the following average annual rates of imports growth: Italy (X% per year) and the United States (X% per year).

In value terms, the United States ($X) constituted the largest supplier of medicaments containing hormones but not antibiotics to Hong Kong SAR, comprising X% of total imports. The second position in the ranking was held by Australia ($X), with an X% share of total imports. It was followed by Italy, with a X% share.

From 2012 to 2022, the average annual growth rate of value from the United States stood at X%. The remaining supplying countries recorded the following average annual rates of imports growth: Australia (X% per year) and Italy (X% per year).

Import Prices by Country

In 2022, the average medicaments containing hormones import price amounted to $X per ton, reducing by X% against the previous year. In general, the import price, however, recorded a buoyant expansion. The most prominent rate of growth was recorded in 2021 when the average import price increased by X% against the previous year. As a result, import price attained the peak level of $X per ton, and then declined significantly in the following year.

Prices varied noticeably by country of origin: amid the top importers, the country with the highest price was the United States ($X,918 per ton), while the price for India ($X per ton) was amongst the lowest.

From 2012 to 2022, the most notable rate of growth in terms of prices was attained by the United States (X%), while the prices for the other major suppliers experienced more modest paces of growth.

Source: IndexBox Platform

Frequently Asked Questions (FAQ) :

The country with the largest volume of medicaments containing hormones consumption was China, accounting for 18% of total volume. Moreover, medicaments containing hormones consumption in China exceeded the figures recorded by the second-largest consumer, India, twofold. The third position in this ranking was occupied by the United States, with a 5.3% share.
The country with the largest volume of medicaments containing hormones production was China, accounting for 18% of total volume. Moreover, medicaments containing hormones production in China exceeded the figures recorded by the second-largest producer, India, twofold. The third position in this ranking was occupied by the United States, with a 5.3% share.
In value terms, the United States constituted the largest supplier of medicaments containing hormones to Hong Kong SAR, comprising 97% of total imports. The second position in the ranking was occupied by Australia, with a 2.6% share of total imports.
In value terms, the Philippines remains the key foreign market for medicaments containing hormones exports from Hong Kong SAR.
In 2021, the average medicaments containing hormones export price amounted to $32,017 per ton, dropping by -16.5% against the previous year.
The average medicaments containing hormones import price stood at $124,681 per ton in 2021, which is down by -22.8% against the previous year.

This report provides an in-depth analysis of the medicaments containing hormones market in Hong Kong SAR, China. Within it, you will discover the latest data on market trends and opportunities by country, consumption, production and price developments, as well as the global trade (imports and exports). The forecast exhibits the market prospects through 2030.

Product coverage:

  • Prodcom 21201250 - Medicaments containing hormones but not antibiotics, for therapeutic or prophylactic uses, not put up in measured doses or for retail sale (excluding insulin)

Country coverage:

  • Hong Kong SAR

Data coverage:

  • Market volume and value
  • Per Capita consumption
  • Forecast of the market dynamics in the medium term
  • Trade (exports and imports) in Hong Kong SAR, China
  • Export and import prices
  • Market trends, drivers and restraints
  • Key market players and their profiles

Reasons to buy this report:

  • Take advantage of the latest data
  • Find deeper insights into current market developments
  • Discover vital success factors affecting the market

This report is designed for manufacturers, distributors, importers, and wholesalers, as well as for investors, consultants and advisors.

In this report, you can find information that helps you to make informed decisions on the following issues:

  1. How to diversify your business and benefit from new market opportunities
  2. How to load your idle production capacity
  3. How to boost your sales on overseas markets
  4. How to increase your profit margins
  5. How to make your supply chain more sustainable
  6. How to reduce your production and supply chain costs
  7. How to outsource production to other countries
  8. How to prepare your business for global expansion

While doing this research, we combine the accumulated expertise of our analysts and the capabilities of artificial intelligence. The AI-based platform, developed by our data scientists, constitutes the key working tool for business analysts, empowering them to discover deep insights and ideas from the marketing data.

  1. 1. INTRODUCTION

    Making Data-Driven Decisions to Grow Your Business

    1. REPORT DESCRIPTION
    2. RESEARCH METHODOLOGY AND AI PLATFORM
    3. DATA-DRIVEN DECISIONS FOR YOUR BUSINESS
    4. GLOSSARY AND SPECIFIC TERMS
  2. 2. EXECUTIVE SUMMARY

    A Quick Overview of Market Performance

    1. KEY FINDINGS
    2. MARKET TRENDS This Chapter is Available Only for the Professional Edition PRO
  3. 3. MARKET OVERVIEW

    Understanding the Current State of The Market and Its Prospects

    1. MARKET SIZE
    2. MARKET STRUCTURE
    3. TRADE BALANCE
    4. PER CAPITA CONSUMPTION
    5. MARKET FORECAST TO 2030
  4. 4. MOST PROMISING PRODUCT

    Finding New Products to Diversify Your Business

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP PRODUCTS TO DIVERSIFY YOUR BUSINESS
    2. BEST-SELLING PRODUCTS
    3. MOST CONSUMED PRODUCT
    4. MOST TRADED PRODUCT
    5. MOST PROFITABLE PRODUCT FOR EXPORT
  5. 5. MOST PROMISING SUPPLYING COUNTRIES

    Choosing the Best Countries to Establish Your Sustainable Supply Chain

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP COUNTRIES TO SOURCE YOUR PRODUCT
    2. TOP PRODUCING COUNTRIES
    3. TOP EXPORTING COUNTRIES
    4. LOW-COST EXPORTING COUNTRIES
  6. 6. MOST PROMISING OVERSEAS MARKETS

    Choosing the Best Countries to Boost Your Exports

    This Chapter is Available Only for the Professional Edition PRO
    1. TOP OVERSEAS MARKETS FOR EXPORTING YOUR PRODUCT
    2. TOP CONSUMING MARKETS
    3. UNSATURATED MARKETS
    4. TOP IMPORTING MARKETS
    5. MOST PROFITABLE MARKETS
  7. 7. PRODUCTION

    The Latest Trends and Insights into The Industry

    1. PRODUCTION VOLUME AND VALUE
  8. 8. IMPORTS

    The Largest Import Supplying Countries

    1. IMPORTS FROM 2012–2023
    2. IMPORTS BY COUNTRY
    3. IMPORT PRICES BY COUNTRY
  9. 9. EXPORTS

    The Largest Destinations for Exports

    1. EXPORTS FROM 2012–2023
    2. EXPORTS BY COUNTRY
    3. EXPORT PRICES BY COUNTRY
  10. 10. PROFILES OF MAJOR PRODUCERS

    The Largest Producers on The Market and Their Profiles

    This Chapter is Available Only for the Professional Edition PRO
  11. LIST OF TABLES

    1. Key Findings In 2023
    2. Market Volume, In Physical Terms, 2012–2023
    3. Market Value, 2012–2023
    4. Per Capita Consumption In 2012-2023
    5. Imports, In Physical Terms, By Country, 2012–2023
    6. Imports, In Value Terms, By Country, 2012–2023
    7. Import Prices, By Country Of Origin, 2012–2023
    8. Exports, In Physical Terms, By Country, 2012–2023
    9. Exports, In Value Terms, By Country, 2012–2023
    10. Export Prices, By Country Of Destination, 2012–2023
  12. LIST OF FIGURES

    1. Market Volume, In Physical Terms, 2012–2023
    2. Market Value, 2012–2023
    3. Market Structure – Domestic Supply vs. Imports, In Physical Terms, 2012-2023
    4. Market Structure – Domestic Supply vs. Imports, In Value Terms, 2012-2023
    5. Trade Balance, In Physical Terms, 2012-2023
    6. Trade Balance, In Value Terms, 2012-2023
    7. Per Capita Consumption, 2012-2023
    8. Market Volume Forecast to 2030
    9. Market Value Forecast to 2030
    10. Products: Market Size And Growth, By Type
    11. Products: Average Per Capita Consumption, By Type
    12. Products: Exports And Growth, By Type
    13. Products: Export Prices And Growth, By Type
    14. Production Volume And Growth
    15. Exports And Growth
    16. Export Prices And Growth
    17. Market Size And Growth
    18. Per Capita Consumption
    19. Imports And Growth
    20. Import Prices
    21. Production, In Physical Terms, 2012–2023
    22. Production, In Value Terms, 2012–2023
    23. Imports, In Physical Terms, 2012–2023
    24. Imports, In Value Terms, 2012–2023
    25. Imports, In Physical Terms, By Country, 2023
    26. Imports, In Physical Terms, By Country, 2012–2023
    27. Imports, In Value Terms, By Country, 2012–2023
    28. Import Prices, By Country Of Origin, 2012–2023
    29. Exports, In Physical Terms, 2012–2023
    30. Exports, In Value Terms, 2012–2023
    31. Exports, In Physical Terms, By Country, 2023
    32. Exports, In Physical Terms, By Country, 2012–2023
    33. Exports, In Value Terms, By Country, 2012–2023
    34. Export Prices, By Country Of Destination, 2012–2023

Recommended reports

Free Data: Medicaments Containing Hormones But Not Antibiotics - Hong Kong SAR